Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Spreen, William"'
Autor:
Hammer SM; Division of Infectious Diseases, Columbia University, New York, New York 10032, USA. smh48@columbia.edu, Ribaudo H, Bassett R, Mellors JW, Demeter LM, Coombs RW, Currier J, Morse GD, Gerber JG, Martinez AI, Spreen W, Fischl MA, Squires KE
Publikováno v:
HIV clinical trials [HIV Clin Trials] 2010 Nov-Dec; Vol. 11 (6), pp. 312-24.
Autor:
Hughes AR; GlaxoSmithKline Genetics, 5 Moore Drive, PO Box 13398, Research Triangle Park, NC 27709, USA. arlene.r.hughes@gsk.com, Brothers CH, Mosteller M, Spreen WR, Burns DK
Publikováno v:
Pharmacogenomics [Pharmacogenomics] 2009 Feb; Vol. 10 (2), pp. 225-33.
Autor:
Hughes S; Infectious Diseases Statistics, GSK Research & Development, Greenford, Middlesex UB6 0HE, UK. sara.h.hughes@gsk.com, Hughes A, Brothers C, Spreen W, Thorborn D
Publikováno v:
Pharmaceutical statistics [Pharm Stat] 2008 Apr-Jun; Vol. 7 (2), pp. 121-9.
Autor:
Demeter LM; University of Rochester, Rochester, New York 14642, USA. lisa_demeter@urmc.rochester.edu, DeGruttola V, Lustgarten S, Bettendorf D, Fischl M, Eshleman S, Spreen W, Nguyen BY, Koval CE, Eron JJ, Hammer S, Squires K
Publikováno v:
HIV clinical trials [HIV Clin Trials] 2008 Jan-Feb; Vol. 9 (1), pp. 11-25.
Publikováno v:
Pharmacogenetics [Pharmacogenetics] 2004 Nov; Vol. 14 (11), pp. 783-4; author reply 784.
Autor:
Lanier ER; GlaxoSmithKline, Research Triangle Park, NC, USA. ernest.r.lanier@gsk.com, Ait-Khaled M, Scott J, Stone C, Melby T, Sturge G, St Clair M, Steel H, Hetherington S, Pearce G, Spreen W, Lafon S
Publikováno v:
Antiviral therapy [Antivir Ther] 2004 Feb; Vol. 9 (1), pp. 37-45.
Autor:
Hetherington S; HIV Clinical Development and Medical Affairs, GlaxoSmithKline, Research Triangle Park, NC 27709, USA. svh31379@gsk.com, Hughes AR, Mosteller M, Shortino D, Baker KL, Spreen W, Lai E, Davies K, Handley A, Dow DJ, Fling ME, Stocum M, Bowman C, Thurmond LM, Roses AD
Publikováno v:
Lancet (London, England) [Lancet] 2002 Mar 30; Vol. 359 (9312), pp. 1121-2.